“You've heard of Ozempic. You've probably heard of Mounjaro. Maybe you've even heard people call these medications game changers, and they are. But the conversation almost always stops at one number. How much weight did you lose?”
Discussed
“You've heard of Ozempic. You've probably heard of Mounjaro. Maybe you've even heard people call these medications game changers, and they are. But the conversation almost always stops at one number. How much weight did you lose?”
“People were losing 10%, 12%, 15% of their body weight in a clinical trial. That was unprecedented for a medication. Then came tirzepatide, Mounjaro, zepbound. This was a dual agonist. It targeted GLP-1 and a second receptor called GIP, glucose-dependent insulinotropic polypeptide.”
“OK? What's a GLP-1? Yeah. The GLP-1s are the weight loss drugs that everybody's talking about. Ozempic, Mounjaro, all the celebrities are on these injections that are making them lose tons of weight. We are starting to look at these drugs in women, but they're not, nobody's looking at it for sexual health.”
“The Wegovy is the FDA approved version for the weight loss. For Tirzepatide, you have Zepbound and Mounjaro, Zepbound being the FDA approved version for weight loss that allows them to keep their patents for longer. These medications are good at transforming medicine, especially where I practice, right?”